TickerFacts.

Iqvia Holdings Inc. (IQV): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.33B
Year ended 2025-12-31
$3.37B
Trailing 12 months to 2026-03-31
+4.3%
3-year compound annual growth
+10.5%
5-year compound annual growth
2011-12-31: $437.25M2012-12-31: $494.72M2013-12-31: $569.84M2014-12-31: $711.00M2015-12-31: $774.00M2016-12-31: $865.00M2017-12-31: $1.68B2018-12-31: $1.88B2019-12-31: $1.98B2020-12-31: $2.02B2021-12-31: $2.66B2022-12-31: $2.93B2023-12-31: $3.10B2024-12-31: $3.32B2025-12-31: $3.33B$3.33B
2011-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$3.33B+0.3%2026-02-17, From 2025-01-01
2024-12-31$3.32B+6.9%2026-02-17, From 2024-01-01
2023-12-31$3.10B+5.9%2026-02-17, From 2023-01-01
2022-12-31$2.93B+10.2%2025-02-13, From 2022-01-01
2021-12-31$2.66B+31.7%2024-02-15, From 2021-01-01
2020-12-31$2.02B+2.0%2023-02-15, From 2020-01-01
2019-12-31$1.98B+5.2%2022-02-16, From 2019-01-01
2018-12-31$1.88B+12.3%2021-02-12, From 2018-01-01
2017-12-31$1.68B+93.8%2020-02-18, From 2017-01-01
2016-12-31$865.00Mn/c2019-02-19, From 2016-01-01
2015-12-31$774.00M+8.9%2018-02-16, From 2015-01-01
2014-12-31$711.00M+24.8%2017-02-16, From 2014-01-01
2013-12-31$569.84M+15.2%2016-02-11, From 2013-01-01
2012-12-31$494.72M+13.1%2015-02-12, From 2012-01-01
2011-12-31$437.25Mn/a2014-02-13, From 2011-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$3.33B+0.3%
Icon PLC (ICLR)2025-12-31$825.84M-45.7%
Incyte Corp (INCY)2025-12-31$1.61B+967.7%
Charles River Laboratories International, Inc. (CRL)2025-12-27$428.47M-27.3%
NRC Health (NRC)2025-12-31$30.21M-26.7%
MaxCyte, Inc. (MXCT)2025-12-31-$47.56Mn/m
OmniAb, Inc. (OABI)2025-12-31-$47.22Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$9.73Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.07Mn/m

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗